India's cancer care system is facing a growing challenge as shortages of two essential chemotherapy drugs Cisplatin and Carboplatin continue to impact treatment schedules at hospitals across the country. The shortage is forcing oncologists to make difficult decisions, including delaying treatments, adjusting dosages, and turning to more expensive alternatives that may not offer the same level of effectiveness.
A major breakthrough in the treatment of Hepatitis B has offered fresh hope to millions of people worldwide. New clinical trials of an experimental drug called bepirovirsen have shown that around 20% of patients achieved a functional cure when the treatment was combined with standard antiviral therapy. The findings were recently published in the prestigious New England Journal of Medicine and presented at one of Europe's largest liver health conferences.
